115 related articles for article (PubMed ID: 9928250)
1. Creation of a constitutively activated state of the 5-HT2A receptor by site-directed mutagenesis: revelation of inverse agonist activity of antagonists.
Egan C; Herrick-Davis K; Teitler M
Ann N Y Acad Sci; 1998 Dec; 861():136-9. PubMed ID: 9928250
[TBL] [Abstract][Full Text] [Related]
2. Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
Egan CT; Herrick-Davis K; Teitler M
J Pharmacol Exp Ther; 1998 Jul; 286(1):85-90. PubMed ID: 9655845
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.
Purohit A; Smith C; Herrick-Davis K; Teitler M
Psychopharmacology (Berl); 2005 May; 179(2):461-9. PubMed ID: 15821958
[TBL] [Abstract][Full Text] [Related]
4. Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.
Muntasir HA; Bhuiyan MA; Ishiguro M; Ozaki M; Nagatomo T
J Pharmacol Sci; 2006 Oct; 102(2):189-95. PubMed ID: 17031071
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor.
Herrick-Davis K; Grinde E; Gauthier C; Teitler M
Ann N Y Acad Sci; 1998 Dec; 861():140-5. PubMed ID: 9928251
[TBL] [Abstract][Full Text] [Related]
6. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
Purohit A; Herrick-Davis K; Teitler M
Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activity of G-protein coupled receptors: emphasis on serotonin receptors.
Teitler M; Herrick-Davis K; Purohit A
Curr Top Med Chem; 2002 Jun; 2(6):529-38. PubMed ID: 12052192
[TBL] [Abstract][Full Text] [Related]
8. Activating mutations of the serotonin 5-HT2C receptor.
Herrick-Davis K; Egan C; Teitler M
J Neurochem; 1997 Sep; 69(3):1138-44. PubMed ID: 9282936
[TBL] [Abstract][Full Text] [Related]
9. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
Herrick-Davis K; Grinde E; Niswender CM
J Neurochem; 1999 Oct; 73(4):1711-7. PubMed ID: 10501219
[TBL] [Abstract][Full Text] [Related]
10. Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo.
Millan MJ; Gobert A; Audinot V; Dekeyne A; Newman-Tancredi A
Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):61S-67S. PubMed ID: 10432490
[TBL] [Abstract][Full Text] [Related]
11. A 5-HT4 receptor transmembrane network implicated in the activity of inverse agonists but not agonists.
Joubert L; Claeysen S; Sebben M; Bessis AS; Clark RD; Martin RS; Bockaert J; Dumuis A
J Biol Chem; 2002 Jul; 277(28):25502-11. PubMed ID: 11976337
[TBL] [Abstract][Full Text] [Related]
12. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
[TBL] [Abstract][Full Text] [Related]
13. Identification of amino acid residues important for sarpogrelate binding to the human 5-hydroxytryptamine2A serotonin receptor.
Muntasir HA; Rashid M; Komiyama T; Kawakami J; Nagatomo T
J Pharmacol Sci; 2006 Sep; 102(1):55-63. PubMed ID: 16974069
[TBL] [Abstract][Full Text] [Related]
14. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors.
Pertz HH; Brown AM; Gager TL; Kaumann AJ
J Pharm Pharmacol; 1999 Mar; 51(3):319-30. PubMed ID: 10344634
[TBL] [Abstract][Full Text] [Related]
15. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
[TBL] [Abstract][Full Text] [Related]
16. Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor.
Rosendorff A; Ebersole BJ; Sealfon SC
Brain Res Mol Brain Res; 2000 Dec; 84(1-2):90-6. PubMed ID: 11113535
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
Herrick-Davis K; Grinde E; Teitler M
J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists.
Berg KA; Maayani S; Goldfarb J; Clarke WP
Ann N Y Acad Sci; 1998 Dec; 861():104-10. PubMed ID: 9928246
[TBL] [Abstract][Full Text] [Related]
20. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
